Small molecule · Agonist of glucocorticoid receptor (NR3C1) · developed by Apothecon
ApprovedFDA, Feb 1965
3Registered trials
What is Triamcinolone Acetonide?
Triamcinolone acetonide is a corticosteroid that binds and activates the glucocorticoid receptor, producing anti-inflammatory and immunomodulating effects. It is studied in osteoarthritis of the knee and glenohumeral joint, and in postoperative ocular inflammation and pain.
Summary written with AI from the sources listed at the end of this page.
Neoplastic diseases (leukemias and lymphomas) (Kenalog-40)
From the indications section of the FDA label (version of Jan 14, 2026). Read the full label for the exact wording, limitations and safety information.
Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z
This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.